在分子水平上对口腔癌的黄素的影响:一个系统的审查
Akhilesh Kumar Singh1, Naresh Kumar Sharma1, Nitesh Mishra1
1Department of Oral and Maxillofacial Surgery, Faculty of Dental Sciences, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India.
National journal of maxillofacial surgery
|June 5, 2023
概括
黄素通过影响分子通路,有效地抑制口腔癌细胞的增殖,迁移和入侵. 需要进一步的临床试验来证实这些对患者有前景的效果.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 口腔癌仍然是一个重大的全球健康挑战.
- 黄是一种来自黄的化合物,显示出潜在的抗癌性质.
- 了解黄素对口腔癌的分子作用对于治疗的发展至关重要.
研究的目的:
- 系统地审查黄素对口腔癌细胞的分子作用.
- 总结关于黄素对增殖,细胞循环和转移的影响的发现.
- 评估黄素作为抗口腔癌剂的潜力.
主要方法:
- 在PubMed,ProQuest,谷歌学者,科学直接和Scopus (2006-2021) 的系统文献搜索.
- 包括关于黄素对口腔癌的影响的体外和体外研究.
- 根据预先定义的标准,对13篇精选文章进行分析.
主要成果:
- 黄素显著降低了口腔癌细胞的增殖和生长 (MTT测试).
- 库尔库明诱导的S阶段细胞周期停止和抑制调节性T细胞 (Treg) 迁移.
- 库尔库逆转了表皮-介质细胞过渡 (EMT) 到介质细胞-表皮细胞过渡 (MET).
结论:
- 黄在口腔癌细胞系中表现出强大的抗增殖,抗迁移,抗侵袭和抗转移作用.
- 黄素诱导了亡并调节了多个信号通路.
- 需要进一步的临床试验来验证黄素在口腔癌患者中的疗效.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancer Therapies
7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K


